| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.092 | 0.002 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.004 |